United States

UDG Healthcare acquires Cambridge Biomarketing

Monday, 17 Jul 2017 02:23am EDT 

July 17 (Reuters) - UDG Healthcare Plc ::Says acquisition of Cambridge Biomarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35 mln.Cambridge Biomarketing is being acquired for an initial consideration of $30 mln, with additional consideration of up to $5 mln .